Concepedia
Statistics
Publications
6
Citations
172
H-Index
Active since
2011
Affiliations
Charité - Universitätsmedizin Berlin(Current)
Humboldt-Universität zu Berlin
University of Cologne
Ludwig-Maximilians-Universität München
German Cancer Research Center
Maria Joosten is an author at Charité - Universitätsmedizin Berlin specializing in oncology, cancer epigenetics, and epigenetics.
Publications per year
2011–2024
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
Felix Carl Saalfeld, Carina Wenzel, Petros Christopoulos et al. · Journal of Thoracic Oncology · 2021 · 64 citations · Full text
Medicine, Immunology, Oncology +14
The histone deacetylase inhibitor trichostatin A reduces lysosomal pH and enhances cisplatin-induced apoptosis
Ida Eriksson, Maria Joosten, Karin Roberg et al. · Experimental Cell Research · 2012 · 45 citations
Life Sciences, Molecular Biology, Oncology +16
Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation
Volkhard Seitz, Karin Zimmermann, Ulrike Paul et al. · Haematologica · 2011 · 22 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype
Maria Joosten, Volkhard Seitz, Karin Zimmermann et al. · Haematologica · 2012 · 15 citations · Full text
Medicine, Molecular Biology, Oncology +17
A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B‐cell lymphoma
Maria Joosten, Sebastian Ginzel, Christian Blex et al. · Molecular Oncology · 2016 · 15 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 6